Log in to save to my catalogue

[11C]DAC-PET for Noninvasively Monitoring Neuroinflammation and Immunosuppressive Therapy Efficacy i...

[11C]DAC-PET for Noninvasively Monitoring Neuroinflammation and Immunosuppressive Therapy Efficacy i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1017981255

[11C]DAC-PET for Noninvasively Monitoring Neuroinflammation and Immunosuppressive Therapy Efficacy in Rat Experimental Autoimmune Encephalomyelitis Model

About this item

Full title

[11C]DAC-PET for Noninvasively Monitoring Neuroinflammation and Immunosuppressive Therapy Efficacy in Rat Experimental Autoimmune Encephalomyelitis Model

Publisher

Boston: Springer US

Journal title

Journal of neuroimmune pharmacology, 2012-03, Vol.7 (1), p.231-242

Language

English

Formats

Publication information

Publisher

Boston: Springer US

More information

Scope and Contents

Contents

Neuroimaging measures have potential for monitoring neuroinflammation to guide treatment before the occurrence of significant functional impairment or irreversible neuronal damage in multiple sclerosis (MS).
N
-Benzyl-
N
-methyl-2-(7-[
11
C]methyl-8-oxo-2-phenyl-7,8-dihydro-9
H
-purin-9-yl) acetamide ([
11
C]DAC), a ne...

Alternative Titles

Full title

[11C]DAC-PET for Noninvasively Monitoring Neuroinflammation and Immunosuppressive Therapy Efficacy in Rat Experimental Autoimmune Encephalomyelitis Model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1017981255

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1017981255

Other Identifiers

ISSN

1557-1890

E-ISSN

1557-1904

DOI

10.1007/s11481-011-9322-3

How to access this item